Medical Oncology Divisions

The Division of Hematologic Malignancies consists of specialized physicians with expertise in various hematologic cancers and palliative care. This team offers advanced clinical care and research opportunities focused on leukemias, myelodysplastic syndromes (MDS), lymphomas, and multiple myeloma-related conditions.

Founded in 1995, the Transplant and Cellular Therapy (TCT) Division at Thomas Jefferson University Hospital has been a leader in advancing treatment for hematologic malignancies, including leukemia, lymphoma, and multiple myeloma. The program offers both autologous and allogeneic stem cell transplants and holds full accreditation from the Foundation for the Accreditation of Cellular Therapy (FACT), a recognition of its commitment to the highest national standards in transplant and cellular therapy care.

In 2008, the Department of Medical Oncology and the Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University established the Division of Population Science to provide a central focus for institutional research activities related to cancer prevention and control.

The Solid Tumor Division is composed of a group of dedicated physicians that have developed disease-oriented subspecialty programs in solid tumor cancers. These physicians work closely with their surgical and radiation oncology colleagues in a multi-disciplinary setting to deliver integrative care with cutting edge research.